Literature DB >> 11326165

The geriatric cancer patient: equal benefit from equal treatment.

L Balducci1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326165

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  14 in total

Review 1.  Pharmacology of anticancer drugs in the elderly population.

Authors:  Hans Wildiers; Martin S Highley; Ernst A de Bruijn; Allan T van Oosterom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokines.

Authors:  S K Brusnahan; T R McGuire; J D Jackson; J T Lane; K L Garvin; B J O'Kane; A M Berger; S R Tuljapurkar; M A Kessinger; J G Sharp
Journal:  Mech Ageing Dev       Date:  2010-10-28       Impact factor: 5.432

3.  Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries.

Authors:  Supriya Gupta Mohile; Ying Xian; William Dale; Susan G Fisher; Miriam Rodin; Gary R Morrow; Alfred Neugut; William Hall
Journal:  J Natl Cancer Inst       Date:  2009-07-28       Impact factor: 13.506

Review 4.  Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights.

Authors:  Nicholas R Harrison; Fabrice J F Laroche; Alejandro Gutierrez; Hui Feng
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

5.  Changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging.

Authors:  Sonal R Tuljapurkar; Timothy R McGuire; Susan K Brusnahan; John D Jackson; Kevin L Garvin; Margaret A Kessinger; Judy T Lane; Barbara J O' Kane; John G Sharp
Journal:  J Anat       Date:  2011-09-16       Impact factor: 2.610

6.  Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy?

Authors:  Andreas A Argyriou; Panagiotis Polychronopoulos; Angelos Koutras; Gregoris Iconomou; Philippos Gourzis; Konstantinos Assimakopoulos; Haralabos P Kalofonos; Elisabeth Chroni
Journal:  Support Care Cancer       Date:  2005-07-15       Impact factor: 3.603

Review 7.  Prognostic factors in chronic lymphocytic leukemia-what do we need to know?

Authors:  Paula Cramer; Michael Hallek
Journal:  Nat Rev Clin Oncol       Date:  2010-10-19       Impact factor: 66.675

Review 8.  Strategies for improving quality of life in older patients with metastatic breast cancer.

Authors:  Jean-Emmanuel Kurtz; Patrick Dufour
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

9.  Predictors of Chemotherapy Related Toxicities in Elderly Lymphoma Patients: Experience from a Tertiary Cancer Centre.

Authors:  Sourav Mishra; Venkatraman Radhakrishnan; Prasanth Ganesan; Rejiv Rajendranath; Swaminathan Rajaraman; Trivadi S Ganesan; Tenali Gnana Sagar
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-25       Impact factor: 0.900

10.  Merckel cell carcinoma: the impact of multidisciplinary management.

Authors:  S Miranda; X Gbaguidi; P Carvalho; J Chassagne
Journal:  J Nutr Health Aging       Date:  2013-02       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.